Creating software to improve MRI research and clinical use
Interoperable Software Platform for Reproducible Research and Clinical Translation of MRI
This study is working on a new software called BART that helps make MRI scans faster and better, so doctors and researchers can share and improve their work together more easily.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Berkeley NIH-funded |
| Lab location | 1 site (Berkeley, United States) |
| Project ID | NIH-10677036 on NIH RePORTER |
What this research studies
This research focuses on developing an interoperable software platform that enhances the reproducibility of MRI research and its clinical applications. By leveraging advanced numerical image reconstruction techniques, the project aims to significantly reduce MRI scan times while maintaining high-quality imaging. The software, known as BART, is designed to be extensible, allowing for the integration of new technological advancements in MRI. This initiative seeks to establish best practices and infrastructure that facilitate collaboration and innovation within the MRI research community.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals requiring MRI scans for diagnostic purposes, particularly those with conditions that benefit from rapid imaging.
Not a fit: Patients who do not require MRI imaging or those with conditions that are not addressed by advancements in MRI technology may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more reliable MRI scans, improving diagnostic capabilities and patient outcomes.
How similar studies have performed: Previous research has shown success in improving MRI techniques through software advancements, indicating a promising potential for this approach.
Where this research is happening
Berkeley, United States
- University of California Berkeley — Berkeley, United States (Active)
Researchers
- Principal investigator: Lustig, Michael — University of California Berkeley
- Study coordinator: Lustig, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.